Bruce Greenberg - May 10, 2022 Form 3 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Interim Chief Financial Officer
Signature
/s/ Bruce Greenberg
Stock symbol
ALDX
Transactions as of
May 10, 2022
Transactions value $
$0
Form type
3
Date filed
5/13/2022, 04:28 PM
Next filing
Jul 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ALDX Common Stock 7.81K May 10, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ALDX Employee Stock Option (Right to Buy) May 10, 2022 Common Stock 45K $5.32 Direct F1
holding ALDX Employee Stock Option (Right to Buy) May 10, 2022 Common Stock 20K $3.57 Direct F2
holding ALDX Employee Stock Option (Right to Buy) May 10, 2022 Common Stock 58.5K $12.24 Direct F3
holding ALDX Employee Stock Option (Right to Buy) May 10, 2022 Common Stock 29.2K $11.28 Direct F3
holding ALDX Employee Stock Option (Right to Buy) May 10, 2022 Common Stock 100K $3.50 Direct F4
holding ALDX Employee Stock Option (Right to Buy) May 10, 2022 Common Stock 73.2K $4.52 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest over 4 years of service following December 12, 2019 with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter.
F2 The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2020.
F3 The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2021.
F4 The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2022.

Remarks:

Interim Chief Financial Officer